Department of Clinical Neurological Sciences, Western University, Ontario, Canada.
Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Alzheimers Dement. 2019 Jul;15(7):961-984. doi: 10.1016/j.jalz.2019.06.001.
The incidence of stroke and dementia are diverging across the world, rising for those in low- and middle-income countries and falling in those in high-income countries. This suggests that whatever factors cause these trends are potentially modifiable. At the population level, neurological disorders as a group account for the largest proportion of disability-adjusted life years globally (10%). Among neurological disorders, stroke (42%) and dementia (10%) dominate. Stroke and dementia confer risks for each other and share some of the same, largely modifiable, risk and protective factors. In principle, 90% of strokes and 35% of dementias have been estimated to be preventable. Because a stroke doubles the chance of developing dementia and stroke is more common than dementia, more than a third of dementias could be prevented by preventing stroke. Developments at the pathological, pathophysiological, and clinical level also point to new directions. Growing understanding of brain pathophysiology has unveiled the reciprocal interaction of cerebrovascular disease and neurodegeneration identifying new therapeutic targets to include protection of the endothelium, the blood-brain barrier, and other components of the neurovascular unit. In addition, targeting amyloid angiopathy aspects of inflammation and genetic manipulation hold new testable promise. In the meantime, accumulating evidence suggests that whole populations experiencing improved education, and lower vascular risk factor profiles (e.g., reduced prevalence of smoking) and vascular disease, including stroke, have better cognitive function and lower dementia rates. At the individual levels, trials have demonstrated that anticoagulation of atrial fibrillation can reduce the risk of dementia by 48% and that systolic blood pressure lower than 140 mmHg may be better for the brain. Based on these considerations, the World Stroke Organization has issued a proclamation, endorsed by all the major international organizations focused on global brain and cardiovascular health, calling for the joint prevention of stroke and dementia. This article summarizes the evidence for translation into action.
中风和痴呆症的发病率在全球范围内存在差异,在中低收入国家呈上升趋势,而在高收入国家则呈下降趋势。这表明导致这些趋势的因素可能是可以改变的。在人群水平上,神经障碍作为一个整体占全球残疾调整生命年(DALY)的最大比例(10%)。在神经障碍中,中风(42%)和痴呆(10%)占主导地位。中风和痴呆相互之间存在风险,并且具有一些相同的、主要可改变的风险和保护因素。原则上,估计 90%的中风和 35%的痴呆症可以预防。由于中风会使痴呆的发病几率增加一倍,而且中风比痴呆更常见,因此通过预防中风可以预防超过三分之一的痴呆症。病理、病理生理学和临床水平的发展也指向了新的方向。对大脑病理生理学的认识不断加深,揭示了脑血管疾病和神经退行性变的相互作用,确定了新的治疗靶点,包括保护内皮细胞、血脑屏障和神经血管单元的其他成分。此外,靶向淀粉样血管病、炎症和遗传操作等方面也有新的、可测试的前景。与此同时,越来越多的证据表明,整个人群如果接受了更好的教育,并且血管危险因素(如吸烟率降低)和血管疾病(包括中风)的发生率降低,那么他们的认知功能会更好,痴呆症的发病率也会更低。在个体层面上,试验已经证明,心房颤动的抗凝治疗可以使痴呆症的风险降低 48%,而收缩压低于 140mmHg 可能对大脑更好。基于这些考虑,世界中风组织发布了一项宣言,得到了所有专注于全球大脑和心血管健康的主要国际组织的认可,呼吁联合预防中风和痴呆症。本文总结了将证据转化为行动的情况。